Minority-Based Community Clinical Oncology Program Groups

by: Iola Bonggay

The National Institutes of Health, more commonly referred to as NIH, is a federal government agency operating under the purview of the United States Department of Health and Human Services that is primarily responsible for supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all magnanimously engineered to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

The primary purpose of the program is to support research initiatives involving physicians who are participating in the care of minorities and who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.

In addition, the program also serves as an opportunity for practicing oncologists who serve large racial/ethnic minority populations to participate in clinical trials sponsored by the National Cancer Institute.

Essentially, this program is designed to cater to minority populations and to bring forth state-of-the-art cancer clinical trials to minority individuals in their own communities.

  (continued...)

Minority-Based Community Clinical Oncology Program Groups
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Genomic Advances to Wound Repair
The National Institutes of Health has coordinated with the National Institute of Nursing Research (NINR) to establish a program called Genomic Advances to Wound Repair in an effort to jump-start research studies that have the potential to deepen the understanding of genomic mechanism associated with the repair and development of wounds that are chronic in nature, which implies that these wounds have failed to enter into a reparative process after three months.

---

Learning Disabilities Innovation Hubs Program
The National Institutes of Health has partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to establish the Learning Disabilities Innovation Hubs Program where both agencies intend to solicit resource-related research project grant applications that concentrate on the etiology, manifestation, prevention, and remediation of writing, reading, or mathematics learning disabilities.

---